Page last updated: 2024-11-03

procainamide and Lupus Nephritis

procainamide has been researched along with Lupus Nephritis in 1 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McLaughlin, K1
Gholoum, B1
Guiraudon, C1
Jevnikar, A1
Muirhead, N1

Other Studies

1 other study available for procainamide and Lupus Nephritis

ArticleYear
Rapid development of drug-induced lupus nephritis in the absence of extrarenal disease in a patient receiving procainamide.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 32, Issue:4

    Topics: Aged; Anti-Arrhythmia Agents; Biopsy; Diagnosis, Differential; Humans; Kidney; Lupus Erythematosus,

1998